1
|
Zou F, McWalter K, Schmidt L, Decker A, Picker JD, Lincoln S, Sweetser DA, Briere LC, Harini C, Marsh E, Medne L, Wang RY, Leydiker K, Mower A, Visser G, Cuppen I, van Gassen KL, van der Smagt J, Yousaf A, Tennison M, Shanmugham A, Butler E, Richard G, McKnight D. Expanding the phenotypic spectrum of GABRG2 variants: a recurrent GABRG2 missense variant associated with a severe phenotype. J Neurogenet 2017; 31:30-36. [PMID: 28460589 DOI: 10.1080/01677063.2017.1315417] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Pathogenic missense and truncating variants in the GABRG2 gene cause a spectrum of epilepsies, from Dravet syndrome to milder simple febrile seizures. In most cases, pathogenic missense variants in the GABRG2 gene segregate with a febrile seizure phenotype. In this case series, we report a recurrent, de novo missense variant (c0.316 G > A; p.A106T) in the GABRG2 gene that was identified in five unrelated individuals. These patients were described to have a more severe phenotype than previously reported for GABRG2 missense variants. Common features include variable early-onset seizures, significant motor and speech delays, intellectual disability, hypotonia, movement disorder, dysmorphic features and vision/ocular issues. Our report further explores a recurrent pathogenic missense variant within the GABRG2 variant family and broadens the spectrum of associated phenotypes for GABRG2-associated disorders.
Collapse
Affiliation(s)
| | | | | | | | - Jonathan D Picker
- b Division of Genetics and Genomics , Boston Children's Hospital , Boston , MA , USA
| | - Sharyn Lincoln
- b Division of Genetics and Genomics , Boston Children's Hospital , Boston , MA , USA.,c NIH Common Fund , Undiagnosed Diseases Network , Bethesda , MD , USA
| | - David A Sweetser
- c NIH Common Fund , Undiagnosed Diseases Network , Bethesda , MD , USA.,d Department of Medical Genetics , Massachusetts General Hospital for Children , Boston , MA , USA
| | - Lauren C Briere
- c NIH Common Fund , Undiagnosed Diseases Network , Bethesda , MD , USA.,d Department of Medical Genetics , Massachusetts General Hospital for Children , Boston , MA , USA
| | - Chellamani Harini
- e Division of Neurophysiology , Boston Children's Hospital , Boston , MA , USA
| | -
- c NIH Common Fund , Undiagnosed Diseases Network , Bethesda , MD , USA
| | - Eric Marsh
- f Division of Child Neurology, Departments of Neurology and Pediatrics , Children's Hospital of Philadelphia , Philadelphia , PA , USA
| | - Livija Medne
- g Individualized Medical Genetics Center, Division of Human Genetics, Division of Neurology , The Children's Hospital of Philadelphia , Philadelphia , PA , USA
| | - Raymond Y Wang
- h Division of Metabolic Disorders , CHOC Children's Hospital , Orange , CA , USA
| | - Karen Leydiker
- h Division of Metabolic Disorders , CHOC Children's Hospital , Orange , CA , USA
| | - Andrew Mower
- i Neurology , CHOC Children's Hospital , Orange , CA , USA
| | - Gepke Visser
- j Wilhelmina Children's Hospital/University Medical Center , Utrecht , the Netherlands
| | - Inge Cuppen
- j Wilhelmina Children's Hospital/University Medical Center , Utrecht , the Netherlands
| | - Koen L van Gassen
- k Department of Genetics , University Medical Center Utrecht , Utrecht , the Netherlands
| | - Jasper van der Smagt
- k Department of Genetics , University Medical Center Utrecht , Utrecht , the Netherlands
| | - Adeel Yousaf
- l University of North Carolina at Chapel Hill , Chapel Hill , NC , USA
| | - Michael Tennison
- m University of North Carolina at Chapel Hill , Chapel Hill , NC , USA
| | | | | | | | | |
Collapse
|